Listen "Autoantibodies against PTM proteins as biomarkers for lupus"
Episode Synopsis
Autoantibodies against post-translationally modified proteins (PTM) are described in various rheumatic diseases and facilitate diagnosis and patient stratification. Researchers from the Leiden University Medical Center analysed the presence of autoantibodies against six different post-translational modifications in a cohort of patients with neuropsychiatric lupus. In this podcast, Leendert Trouw, Rory Monahan and Michelle van den Beukel discuss the results of their study with the ARD/RMDopen social media advisor Caroline Ospelt.
Read the Open Access related paper: https://rmdopen.bmj.com/content/8/1/e002079
Listen to more episodes of RMD Open: https://podcasts.apple.com/gb/podcast/rmd-open-rheumatic-and-musculoskeletal-diseases/id1237127864
Read the Open Access related paper: https://rmdopen.bmj.com/content/8/1/e002079
Listen to more episodes of RMD Open: https://podcasts.apple.com/gb/podcast/rmd-open-rheumatic-and-musculoskeletal-diseases/id1237127864
More episodes of the podcast BMJ talk medicine
Primary Survey - the highlights of June 2023
02/06/2023
Aciclovir PEP after VZ exposure in pregnancy, falls and fractures with aspirin, an inclisiran rant
31/05/2023
Atoms: the highlights from the ADC June 2023
26/05/2023
Quantity AND Quality Is Key For People With Knee OA – Dr Kerry Costello And Dr Deepak Kumar. EP#531
26/05/2023
Editors Highlights of the June 2023 issue
25/05/2023
How to model safe clinical practice
23/05/2023
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.